Tenax Therapeutics

Tenax Therapeutics is focused on developing and commercializing pharmaceutical products that improve outcomes for patients who require treatment for various critical care conditions.

Our development portfolio includes novel product candidates that have the potential to address various critical care conditions with high unmet medical need.

Type
Public
HQ
Morrisville, US
Size (employees)
10 (est)
Tenax Therapeutics is headquartered in Morrisville, US

Tenax Therapeutics Office Locations

Tenax Therapeutics has office in Morrisville
Morrisville, US

Tenax Therapeutics Metrics

Tenax Therapeutics Summary

Market capitalization

$16.1 m

Closing share price

$0.6
Tenax Therapeutics's current market capitalization is $16.1 m.

Tenax Therapeutics Financials

Tenax Therapeutics's revenue is $158.9 k in FY, 2014 which is a 222.5% increase from the previous period.
FY, 2014FY, 2015

Revenue

$158.9 k$49.3 k

Revenue growth, %

(69%)

Net Income

($19.5 m)($14.1 m)

Tenax Therapeutics Market Value History

Tenax Therapeutics Company Life

You may also be interested in